1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Novel Vaccine Delivery Systems Market by Delivery Mode, Device : Global Opportunity Analysis and Industry Forecast, 2021–2030.

Novel Vaccine Delivery Systems Market by Delivery Mode, Device : Global Opportunity Analysis and Industry Forecast, 2021–2030.

  • June 2021
  • 208 pages
  • ID: 6126677
  • Format: PDF
  • Allied Market Research

Summary

Table of Contents

Novel Vaccine Delivery Systems Market by Delivery Mode (Intradermal, Subcutaneous, Intramuscular, and Other), Device (Syringe, Needle-Free Injection System, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.

The global novel vaccine delivery systems market was valued at $5,030 million in 2020 and is projected to reach $14,437 million by 2030 registering a CAGR of 10.8% from 2021 to 2030.
Vaccines, often known as immunizations, inject a weakened form of a pathogen into a person to cause the body to produce antibodies or immunity against the illness. A number of diseases with significant mortality rates, such as polio and smallpox, have been eliminated owing to effective vaccinations. Vaccinations are used in a variety of regional disease-prevention programs since they serve such an important role in maintaining people’s long-term health in different countries. The need for immunizations has risen in recent years as the frequency of viral and bacterial infectious illnesses has increased. Vaccines are essentially administered to people of different age groups, which strengthen their immune system throughout lifetime and offers protection against different types of infectious diseases. The term "novel vaccine delivery" refers to the systems that are used to safely deliver an active medicinal component into the body.
The driving factors that drive the novel vaccine delivery systems market growth include, growing immunization programs & their increasing coverage, increasing government support for various immunization programs and investment for R & D to develop new vaccines. In addition, development of novel vaccines for treating various diseases further boosts the growth of the market. However, high cost and unaffordability of safety syringes as well as alternative modes of drug delivery restrains the growth of the market. In contrast, rise in need for safety syringes in emerging economies and FDA approval to COVID 19 Vaccine create lucrative opportunities for the novel vaccine delivery system.
The global novel vaccine delivery systems market is segmented into delivery mode, device and region. On the basis of delivery mode, the market is categorized into intradermal, subcutaneous, intramuscular, and other. By device, it is classified into syringe, needle-free injection system, and others. Syringe again classified into conventional syringe and smart syringe. Smart syringe again segmented into active safety syringes, passive safety syringes, and auto disable syringes. Needle-free injection system again classified into spring-based injector systems, gas propelled/air forced injector system, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global novel vaccine delivery systems market along with the current trends and future estimations to explain the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of novel vaccine delivery systems used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Delivery Mode
• Intradermal
• Subcutaneous
• Intramuscular
• Other

By Device
• Syringe
o Conventional Syringe
o Smart Syringe
Active Safety Syringes
Passive Safety Syringes
Auto Disable Syringes
• Needle free injection System
o Spring-based Injector Systems
o Gas Propelled/Air Forced Injector Systems
o Others
• Others

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Altaris Capital Partners, LLC (Kindeva Drug Delivery)
• Becton, Dickinson, and Company
• Carl Zeiss Foundation (Schott AG)
• Gerresheimer AG
• Gurnet Point Capital (Corium International Inc.)
• Inovio Pharmaceuticals, Inc. (Bioject Medical Technologies)
• PharmaJet, Inc.
• Retractable Technologies, Inc.
• Terumo Corporation
• VAXXAS Pty Ltd.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Epinephrine Auto-Injector Market Research Report by Dosage, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • $ 4949
  • October 2021
  • 180 pages

Epinephrine Auto-Injector Market Research Report by Dosage (0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, and Mg Epinephrine Autoinjector), by End-User (Clinics, Hospital, and Individual), ...

  • World
  • Injectable Delivery
  • Cardiovascular Drug
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on